Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_assertion type Assertion NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_head.
- NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_assertion description "[In the first stage of the screening for 16 genes, we compared lung cancer tissues with their adjacent non-malignant tissues at the mRNA level, and found six genes (ERGIC3, DDR1, HSP90B1, SDC1, RPSA, and LPCAT1) from the FSL were significantly up-regulated while two genes (GPX3 and TIMP3) from the RSL were significantly down-regulated (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_provenance.
- NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_assertion evidence source_evidence_literature NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_provenance.
- NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_assertion SIO_000772 23374247 NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_provenance.
- NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_assertion wasDerivedFrom befree-20140225 NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_provenance.
- NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_assertion wasGeneratedBy ECO_0000203 NP416061.RAl5C26Mscorq6BzC_9DrUKEsrA51grmLBt0a9_f5OlU8130_provenance.